Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...

NICE has recommended broadening NHS use of Novartis' IL-17 inhibitor Cosentyx to include children aged six to 17 with severe plaque psoriasis. The cost-effectiveness agency says in draft guidance ...

I woke up one morning to find three huge patches of psoriasis on my scalp, two of which were clumped right together right at the front of my scalp. They formed what looked like-- with all the ...

Inflammatory skin conditions are common, with one in five children and one in 10 adults in the UK living with eczema. Though much less common, around one in 50 people in the UK have psoriasis.

“From a systemic agent standpoint, we’ve never had an oral agent approved for psoriasis,” Eichenfield, who is chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

The condition that Aaron Ribner battles is psoriasis—a non-contagious skin disorder that currently has no cure and afflicts between two and three percent of the world's population. For those ...